MedTrace Logo

ADenosine Vasodilator Independent Stenosis Evaluation II - ADVISE II

NCT01740895 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 818

Last updated 2014-08-06

No results posted yet for this study

Summary

To assess the clinical value of iFR to characterize, without concomitant administration of hyperemic agents and outside a specified range of iFR values, coronary stenosis severity as determined with fractional flow reserve (FFR)

Conditions

Sponsors & Collaborators

  • Volcano Corporation

    lead INDUSTRY

Principal Investigators

  • Javier Escaned, MD · Hospital Cl¡nico San Carlos Madrid Spain

  • Amir Lerman, MD · Mayo Clinic Rochester MN USA

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States
  • Canada
  • Egypt
  • Germany
  • Netherlands
  • Poland
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01740895 on ClinicalTrials.gov